Dendrimers have attracted great interest in the field of gene delivery due to their synthetic controllability and excellent gene transfection efficiency. In this work, dendrigraft poly-L-lysines (DGLs) were evaluated as a novel gene vector for the first time. Derivatives of DGLs (generation 2 and 3) with different extents of PEGylation were successfully synthesized and used to compact pDNA as complexes. The result of gel retardation assay showed that pDNA could be effectively packed by all the vectors at a DGLs to pDNA weight ratio greater than 2. An increase in the PEGylation extent of vectors resulted in a decrease in the incorporation efficiency and cytotoxicity of complexes in 293 cells, which also decreased the zeta potential a little but did not affect the mean diameter of complexes. Higher generation of DGLs could mediate higher gene transfection in vitro. Confocal microscopy and cellular uptake inhibition studies demonstrated that caveolae-mediated process and macropinocytosis were involved in the cellular uptake of DGLs-based complexes. Also the results indicate that proper PEGylated DGLs could mediate efficient gene transfection, showing their potential as an alternate biodegradable vector in the field of nonviral gene delivery.
Introduction
Developing efficient and nontoxic gene carriers is the most demanding task in the field of nonviral gene therapy. Cationic polymers are one of the most popular nonviral gene vectors due to their synthetic controllability and excellent ability to compact anionic genes [1, 2] . Several kinds of cationic polymers including polyethylenimine (PEI), poly-L-lysine (PLL) and chitosan, have been reported to mediate efficient gene transfection of different cell lines [3, 4] .
In the last two decades of research in materials science, dendrimers have been studied well as a gene delivery module [1, 2] . Dendrimers are known for their threedimensional, monodispersed, highly branched macromolecular nanoscopic architecture with a number of reactive end groups [5] . Dendritic polymers mainly bearing primary amine groups on the branched surface can bind with DNA via electrostatic interaction, and compact DNA into polyplexes, which could protect DNA from degradation and promote the cellular uptake of genes [1, 2] . Among these, polyamidoamine (PAMAM) dendrimers have attracted great interest due to their high efficacy in gene delivery [6] . However, cationic PAMAM dendrimers are associated with bio-incompatibility, which limits their wide application in vitro and in vivo. Conjugation of polyethylene glycol (PEG) could efficiently decrease their cytotoxicity by reducing, or partially shielding, the positive charge on the surface of PAMAM dendrimers [7, 8] . In spite of this, the non-degradability of PAMAM is still a problem.
Dendrimers based on poly-L-lysine (PLL) are promising new candidates due to their biodegradable properties. PLLbased dendrimers have already been exploited in constructing drug delivery systems. Kaminskas and co-workers conjugated methotrexate (MTX) to a series of PEGylated PLL dendrimers, and demonstrated their potential as long-circulating vectors for the delivery and tumor-targeting of hydrophobic drugs [9] . Fox and colleagues also attached camptothecin (CPT) covalently to PEGylated PLL dendrimers, and demonstrated the significantly prolonged survival in tumor-bearing mice compared to free CPT [10] .
Agrawal and colleagues demonstrated that PLL dendrimers coated with galactose could be utilized for controlled delivery of chloroquine phosphate, a kind of antimalarial agent [11] . Moreover, modified PLLbased dendrimers could provide useful antibiotic and antiviral properties in their own right [12, 13] . However, most of the PLL-based dendrimers used were synthesized by the researchers themselves. The structures of these PLL-based dendrimers are not exactly the same, which significantly limits the prevalence of these dendrimers.
Fortunately, dendrigraft poly-L-lysines (DGLs), a kind of PLL-based dendrimers, are now commercially available. They are cationic, biodegradable, monodispersed, and well-defined, possessing the main properties of PLLbased dendrimers.
Current studies are focused on the physicochemical characterization of DGLs [14] [15] [16] . To our knowledge, DGLs have never been used in the field of drug delivery. In this study, DGLs were exploited as a gene delivery vector for the first time. The impact of PEGylation on the gene transfection efficiency and intracellular trafficking process of DGLs were systematically evaluated.
Materials and methods

Materials
Dendrigraft poly-L-lysines (DGLs) (containing 48 and 123 primary amino groups for generation 2 and 3, respectively) were purchased from COLCOM (Montpellier Cedex, France). PAMAM dendrimers (generation = 5, containing 128 primary amino groups) were purchased from DENDRITECH (Midland, MI, USA). α-methoxyl-ω-N-hydroxysuccinimidyl polyethyleneglycol (MeO-PEG-NHS, MW 3500) was obtained from JenKem Technology Co., Ltd (Beijing, China). The BODIPY fluorophore (4,4-difluoro-5,7-dimethyl-4-bora-3a, 4a-diaza-s-indacene-3-propionic acid, sulfosuccinimidyl ester, sodium salt), ethidium monoazide bromide (EMA), YOYO-1 iodide, LysoTracker Green and LysoTracker Red were purchased from Molecular Probes (Eugene, OR, USA). The plasmid pEGFP-N2 (Clontech, USA) and pGL2-Control Vector (Promega, USA) were purified using a QIAGEN Plasmid Mega Kit (Qiagen GmbH, Germany). Dulbecco's Modified Eagle Medium (DMEM) and fetal bovine serum (FBS) were purchased from Gibco (Tulsa, OK, USA). Human holo-Tf, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), phenylarsine oxide (PhAsO), filipin complex (from streptomyces filipinesis), colchicine, and other reagents, if not specified, were purchased from Sigma-Aldrich (St Louis, MO, USA).
Synthesis of different vectors
In this study, two generations of DGLs were selected, D2 (generation 2) and D3 (generation 3). Different conjugates of DGLs and PEG3500-NHS were prepared through specific reaction between the primary amino groups on the surface of the DGLs and the NHS groups of the bifunctional PEG. Briefly, the purchased D2 and D3 were dried under a nitrogen atmosphere to remove the methanol solution. PEG was dissolved in phosphate-buffered solution (PBS, pH 8.0). The reaction was performed at room temperature for 2 h. The molecular ratios of DGLs and PEG were 1:2, 1:5 and 1:10, respectively. The resulting conjugates were purified by ultrafiltration using a 5 kDa molecular weight cutoff membrane to remove unreacted PEG and the buffer was exchanged into PBS (pH 7.4). The purified vectors were designated as D2-PEG 2 , D2-PEG 5 , D2-PEG 10 , D3-PEG 2 , D3-PEG 5 , D3-PEG 10 , respectively.
For the synthesis of BODIPY-labeled vectors, DGLs were first reacted with BODIPY in 100 mM NaHCO 3 for 12 h at 4
• C, and purified by ultrafiltration using a 5 kDa molecular weight cutoff membrane to remove unreacted BODIPY. The BODIPY-labeled DGLs were used to synthesize different BODIPY-labeled vectors as described above.
1 H-NMR analysis of different vectors
The characteristics of different vectors were analyzed by nuclear magnetic resonance (NMR) spectroscopy. Different vectors were dissolved in D 2 O and analyzed in a 400 MHz spectrometer (Varian, USA).
Preparation of different complexes
Different vectors were freshly prepared and diluted to appropriate concentrations in PBS (pH 7.4). Plasmid DNA (pDNA) solution (100 μg pDNA ml −1 50 mM sodium sulfate solution) was added to obtain specified weight ratios and immediately vortexed for 30 s at room temperature. Freshly prepared complexes were used in the following experiments.
Plasmid DNA was covalently labeled with fluorescent dye, EMA, to locate its intracellular position. Fresh pDNA solution (1 mg ml −1 0.05 M Tris-HCl buffer, pH 8.0) was diluted with an aqueous solution of EMA (0.1 mg ml −1 ) and incubated for 30 min in the dark. The complexes were then exposed to UV light for 1 h, and the resulting solution was precipitated by the addition of ethanol to a final concentration of 30% (v/v). The precipitates were collected by centrifugation and further dissolved in 50 mM sodium sulfate solution to obtain EMAlabeled pDNA.
EMA-labeled complexes were prepared as described above using EMA-labeled pDNA. Likewise, BODIPY-labeled complexes were prepared using BODIPY-labeled vectors to locate their intracellular position.
Gel retardation assay
Agarose gel retardation assay was carried out to determine the pDNA binding ability of different vectors. Vector/pDNA complexes were prepared at various weight ratios (DGLs to pDNA, w/w) ranging from 0.05:1 to 10:1. The complexes were mixed with appropriate amounts of 6× loading buffer and then electrophoresced on a 0.9% (w/v) agarose gel containing ethidium bromide (0.25 μg ml −1 of the gel). The location of pDNA in the gel was analyzed on a UV illuminator and photographed using a Canon IXUS 950IS camera.
Characterization of different complexes
The mean diameter and zeta potential of different complexes, with a DGLs to pDNA weight ratio at 10:1, were determined by dynamic light scattering using a Zeta Potential/Particle Sizer Nicomp™ 380 ZLS (PSS Nicomp Particle Size System, USA).
Cell culture
Human embryonic kidney cells (HEK 293 cells) were cultured in complete medium (DMEM containing 10% (v/v) FBS supplemented with 100 U ml −1 penicillin and 100 μg ml −1 streptomycin) at 37
• C under a humidified atmosphere containing 5% CO 2 . The cells were purchased from Shanghai Cell Bank, Chinese Academy of Medical Sciences.
Cytotoxicity determination
The cytotoxicity of different complexes was evaluated by MTT assay, as described previously [17] . Briefly, HEK 293 cells were seeded at a density of 1 × 10 4 cells/well in a 96-well plate. Upon 48 h incubation, different complexes with a DGLs to pDNA weight ratio at 10:1 were added in various concentrations (5, 10, 20, 50, 100, 200, 500 and 1000 μg ml −1 , calculated by DGLs). After 3 h incubation, the complexes were removed, and 100 μl of 0.5 mg ml −1 MTT in PBS (pH 7.4) was added, incubating for another 2 h. Then the medium was replaced with 100 μl of dimethylsulfoxide (DMSO) to dissolve the insoluble formazan crystals. The absorbance was measured at a microplate reader with 570 nm as the excitation wavelength and 630 nm as the background. The viability of HEK 293 cells exposed to the complexes was expressed as a percentage of the viability of cells grown in the absence of the complexes. The PAMAM G5 (generation 5)/DNA complexes were prepared in the same way as described above and used as controls.
Transfection efficiency measurements
HEK 293 cells were seeded in 24-well plates (CorningCoaster, Tokyo, Japan) at a density of 2 × 10 4 cells/well. Cultured for 48 h, the cells reached 70% confluence. The complexes containing pEGFP, with DGLs to pDNA at weight ratio 10:1, were added to the cells in FBS-free medium and the mixture was incubated at 37
• C for 1 h. After 48 h, fluorescent images were acquired and photographed under the Olympus IX51 microscope. The efficiency of gene transfer for quantitative analysis was determined by luciferase activity using pGL2-Control Vector. Two days post-transfection, the activity of luciferase was quantified by a Luciferase Assay System (Promega, Madison, WI, USA) according to the manufacturer's instructions. Briefly, the cells were lysed in a sufficient volume of cell culture lysis buffer (Promega, Madison, WI, USA). The lysate was vortexed for 15 s, and then centrifuged at 12 000g for 2 min at 4
• C. The supernatant was assayed for luciferase activity and the emitted light was measured over 10 s using a chemiluminescence analyzer (BPCL, Peking, China) giving light units. The light units were normalized to protein amounts in the cell extracts, determined by the Bio-Rad Protein Assay Kit, to light units mg −1 protein. In these experiments, PAMAM G5/DNA complexes and commercially available Lipofectamine 2000 were exploited as positive controls.
Intracellular trafficking studies using confocal microscopy
To investigate the intracellular fate of D3/DNA complexes, a series of studies using confocal microscopy were designed. Firstly, D3/DNA complexes, prepared using BODIPY-labeled D3 and EMA-labeled pDNA, were used to investigate whether the vectors and pDNA maintained a complexing state within the cells. Secondly, BODIPY-labeled D3 was used to complex with pDNA, while the acid compartments were labeled with LysoTracker Red. Thirdly, EMA-labeled pDNA was applied to complex with D3, while the acid compartments were labeled with LysoTracker Green. Finally, EMA-labeled D3/DNA complexes were prepared using EMAlabeled pDNA, while BODIPY-labeled PAMAM G5/DNA complexes were prepared using BODIPY-labeled PAMAM G5, to investigate whether D3/DNA complexes possessed the similar intracellular processes as PAMAM G5/DNA complexes.
HEK 293 cells were seeded in 33 mm dishes at a density of 5 × 10 4 cells/dish and incubated for 48 h. The medium was removed and the cells were pretreated with fluorescent dye, LysoTracker Green or LysoTracker Red, for 10 min to label the acid compartments, including endosomes and lysosomes, where red EMA and green BODIPY was used to label pDNA and vectors, respectively. Then the cells were incubated with D3/DNA complexes labeled with different dyes for 15 min and 60 min, respectively, plus PAMAM G5/DNA complexes when the mechanism relationship between these two cationic polymer-based polyplexes was studied. After incubation, the wells were washed three times with 2 ml PBS and examined using a confocal microscope (LeicalTCS SP2 AOBS) excited at 560 nm for red dye observation and 488 nm for green dye observation.
Cellular inhibition studies
HEK 293 cells were seeded at a density of 4 × 10 4 cells/well in a 24-well plate, incubated for 48 h, and checked under the microscope for confluency and morphology. The medium was removed and the cells were pretreated with PhAsO (2.5 μM), filipin (0.5 μg μl −1 ), colchicine (2.5 μM), Tf (2.5 μM), and PAMAM G5 (120 μg ml −1 ) for 10 min at 37
• C. PhAsO is reported to inhibit clathrin-dependent endocytosis [18] , and filipin is known to block caveolae-mediated processes [19] . Colchicine is an inhibitor of macropinocytosis [20] . Tf induces both clathrin-dependent pathways and cationic inhibition, while PAMAM induces inhibition of caveolae-dependent endocytosis, macropinocytosis, and positive charges. Here, YOYO-1 dye was applied to fluorescently label pDNA [21] . Subsequently, cells were incubated with YOYO-labeled 
Statistical analysis
Quantitative measurements were collected in quadruplicate, and the experiments were repeated four times. The data are expressed as mean ± standard error of the mean (SEM). Statistical analysis was performed by one-way ANOVA followed by Bonferroni's post-test using Stata software (version 7.0).
Results
Characterization of different vectors using 1 H-NMR
In the NMR spectra shown in figure 1 the solvent peak of D 2 O was found around 4.65 ppm. Peaks between 1 and 1.8 ppm represent H protons of 3CH 2 in lysine units. The peak around 2.8 ppm is representative of H protons of 1CH 2 epsilon, while that around 4.1 ppm represents H protons on the chiral C in lysine units. The different PEGylated vectors possess a sharp peak at 3.5 ppm, representing the repeat units of PEG [22] . Furthermore, the integrated areas of NMR peaks were used to quantify the number of PEG chains per DGLs with the assumption of 280 methylene protons per PEG, 48 lysine units per D2, and 123 lysine units per D3. The calculated molecular ratios of DGLs to PEG chains are shown in figure 1 . The NMR spectra and the calculated values demonstrated the successful synthesis of different PEGylated vectors. The peak localization of D2 and its PEGylated derivatives in the NMR spectra is almost the same as its D3 counterparts.
Gel retardation assay
As shown in figure 2 , the gel retardation assay demonstrated that pDNA could be effectively packed by all the used vectors at a DGLs to pDNA weight ratio greater than 2, since the mobility of the pDNA was significantly retarded. When the weight ratio increased to 10, vectors could completely incorporate the pDNA, which could no longer be intercalated by ethidium bromide. Increasing the PEGylation extent of the vectors decreased the incorporation efficiency, which might be attributed to the decreasing positive charges of the vectors.
Size and zeta potential of different complexes
The mean diameter of different complexes was around 100 nm, while the zeta potential value was around 5 mV (table 1) . Increasing the PEGylation extent of vectors decreased the zeta potential a little, but did not affect the mean diameter of complexes. There existed no apparent difference in the mean diameter and potential between D2-and D3-based complexes prepared in this study.
Cytotoxicity assay
The result of the percentage cell viability after 3 h incubation of different complexes with HEK 293 cells using MTT assay is shown in figure 3 . None of the complexes showed apparent cytotoxicity at concentrations lower than 200 μg ml −1 . The percentage cell viabilities of all complexes were higher than 70% at 200 μg ml −1 concentration: 82.7 ± 2.6% for D2/DNA, 86.2 ± 3.0% for D2-PEG 2 /DNA, 93.9 ± 8.4% for D2-PEG 5 /DNA, 92.4 ± 7.0% for D2-PEG 10 /DNA, 78.4 ± 3.9% for D3/DNA, 96.7 ± 5.6% for D3-PEG 2 /DNA, 92.6 ± 4.1% for D3-PEG 5 /DNA, 101.6 ± 9.6% for D3-PEG 10 /DNA, and 74.0 ± 6.2% for PAMAM G5/DNA (figure 3). When the concentration increased to 500 μg ml −1 , percentage cell viability significantly decreased. At higher concentrations, the result demonstrated that higher PEGylation extent exhibited lower cytotoxicity, indicating the positive effect of PEG to reduce the cytotoxicity of cationic polymers. The cytotoxicity of D3/DNA complexes was lower than PAMAM G5/DNA complexes at higher concentrations. Based on the cytotoxicity result, the concentration of complexes, 200 μg ml −1 , was chosen in the following experiments. protein, respectively (figure 5).
Gene transfection efficiency
Confocal microscopy studies
Different experiments were designed to illuminate the intracellular processes of D3/DNA complexes using confocal microscopy. As shown in figure 6 , some pDNA maintained complexed with D3 and some decomplexed as naked pDNA in cytoplasm. D3 could facilitate pDNA to the nucleus and showed excellent nuclear localization itself. The cellular uptake of D3/DNA complexes for 60 min incubation was higher than that for 15 min incubation. As shown in figures 7 and 8, neither BODIPY-labeled or EMA-labeled D3/DNA complexes apparently co-localized with acid compartments including endosomes and lysosomes, which were stained with LysoTracker Red or LysoTracker Green, respectively. The BODIPY-labeled D3/DNA complexes showed some colocalization with acid compartments at 60 min while EMAlabeled ones mainly exist in the cytoplasm. These results indicate that D3/DNA complexes might not primarily be taken up by HEK 293 cells through endosome-lysosome pathways. In addition, EMA-labeled D3/DNA complexes partly co-localized with BODIPY-labeled PAMAM G5/DNA complexes, suggesting that these two kinds of complexes did not share exactly the same cellular uptake mechanisms (figure 9). Thus cellular uptake studies using different inhibitors were carried out to investigate the relevant mechanisms.
Cellular uptake inhibition studies
The impacts of different inhibitors in the cellular uptake of D3/DNA complexes are shown in figure 10 using a fluorescence microscope. The results show that the cellular uptake of D3/DNA complexes could clearly be observed. This cellular uptake was significantly inhibited by filipin (an inhibitor of caveolae-mediated process), colchicine (an inhibitor of macropinocytosis), excessive Tf and PAMAM, but not impacted by PhAsO (an inhibitor of clathrin-dependent endocytosis). The extent of inhibition by PAMAM was more significant than by other inhibitors.
Discussion
For the first time, DGLs were exploited as a kind of nonviral gene vector. In this study, different PEGylated DGLs-based vectors were successfully synthesized. The relevant characteristics and cellular uptake mechanisms were investigated systematically in vitro. DGLs are considered to possess potential as gene delivery vectors based on the current extensive studies on PAMAM dendrimers. Several lines of investigation have demonstrated that PAMAM could mediate effective gene transfection in vitro and in vivo [17, [22] [23] [24] [25] . DGLs have similar features to PAMAM, containing several primary amino groups. The positive charges in the amino groups on DGLs play a key role, which help in compacting pDNA, binding with negative cellular membranes and in cellular uptake. In this study, DGLs exhibited a DNA-loading capability as a potential gene transfection reagent. The gene transfection efficiency of D3/DNA complexes was comparable to that of PAMAM G5/DNA complexes (figures 4 and 5). This might be attributed to the similar number of free amino groups in D3 (123 amino groups per D3 molecule) and PAMAM G5 (128 amino groups per PAMAM G5 molecule). However, the distribution of amino groups in DGLs was different from that in PAMAM. For DGLs, some amino groups locate on the surface while others are within the dendrimers [15] . For PAMAM, all the free amino groups locate on the surface [26] . Thus, the complexation of DGLs and pDNA might be not exactly the same as that of PAMAM and pDNA. This difference was reflected in the size and zeta potential measurements. The size and zeta potential of DGLs/DNA complexes were around 100 nm and 5 mV (table 1) while those of PAMAM/DNA complexes was near 200 nm and 25 mV, respectively [27] . The lower zeta potential of DGLs/DNA complexes also resulted in lower cytotoxicity in HEK 293 cells compared to PAMAM G5/DNA complexes ( figure 3 ). In addition, this difference might at the same time result in different cellular uptake mechanisms for DGLs and PAMAM ( figure 9) .
Nowadays, PEG is widely used to improve the biocompatibility of cationic dendrimers [8, [28] [29] [30] . PEG conjugation could significantly decrease the in vitro and in vivo cytotoxicity and hemolysis of PAMAM dendrimers [8, 29, 31] . PEGylation technique has also been introduced to studies in PLL-based dendrimers.
Kaminskas and colleagues demonstrated that conjugation of PEG on PLL dendrimers could markedly reduce plasma clearance and enhance metabolic stability in vivo [9, 32, 33] , which is consistent with the results reported by Fox's group [10] . Based on this, DGLs conjugated with different numbers of PEG molecules were investigated in this study. The results showed that PEGylation could reduce the positive charges of DGLs (figure 2), resulting in lower cytotoxicity (figure 3), but did not affect the size of complexes greatly (table 1) . A higher PEGylation extent exhibited a stronger shielding effect which might slightly decrease the zeta potential of the DGLs/DNA complexes. The gene transfection efficiency of the complexes was increased with the PEGylation extent in DGLs, and this effect reached a plateau when further increasing the PEG ratios (figures 4 and 5). The lower transfection efficiency at lower PEGylation extent might be due to the higher cytotoxicity. These results were in good agreement with the published paper which demonstrated that 8% PEGylated PAMAM G5 and G6 possessed a higher gene expression compared to its 4% and 15% PEGylated counterparts [29] . However, it has been reported that fully PEGylated PLL dendrimers had a greater ability to increase plasma stability and circulation time compared with partly PEGylated dendrimers [33] , indicating that increasing PEGylation extent might induce enhanced gene transfection efficiency in vivo.
In this study, the intracellular trafficking process and cellular uptake mechanism of DGLs/DNA complexes were systemically investigated. The uptake by HEK293 cells might not be limited to a single mechanism. Several mechanisms, including caveolae-mediated process and macropinocytosis, were involved. It has been reported that the internalization of PAMAM or its derivatives complexed with pDNA occurred via a caveolae-mediated process and macropinocytosis due to the features of PAMAM [34, 35] . For the similar dendritic structural basis of DGLs and PAMAM, the cellular uptake of D3/DNA complexes might also be attributed to the cationic and highly branched properties of DGLs. That is why the cellular uptake of D3/DNA complexes was significantly inhibited by PAMAM ( figure 10(F) ). However, subcellular co-localization data showed that most D3/DNA complexes did not apparently track to acid compartments (figures 7 and 8), suggesting that some other cellular uptake mechanisms might be involved. The slight inhibition induced by Tf was supposed to relate to the unit of lysine, which is also one of the amino acids for proteins. As DGLs are a kind of novel polymer, there exists huge scope for researchers to explore.
Conclusion
In summary, proper PEGylated DGLs could mediate efficient gene transfection in vitro, showing their potential as efficient biodegradable gene delivery vectors with low cytotoxicity. Caveolae-mediated processes and macropinocytosis were involved in the cellular uptake of D3/DNA complexes. In future studies, PEGylated DGLs will be evaluated as gene transfection reagents in vivo. In addition, DGLs themselves showed excellent ability for nuclear accumulation, suggesting their great potential for delivering chemotherapeutic drugs such as doxorubicin to the nucleus.
